Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 301 - 350 out of 14,031

Document Document Title
WO/2013/061004
The present invention relates to novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds corresponding to the following general formula (I): , to the pharmaceutical compositions containing these compounds and also to the use of...  
WO/2013/059582
The disclosure relates to small molecules and methods, compositions, and kits comprising these small molecules. In still another embodiment, the disclosure relates to small molecules that inhibit HDAC activity. In yet another embodiment,...  
WO/2013/058631
The present invention relates to a diterpene furanoids compound which inhibits an activity of protein tyrosine phosphatase 1B (PTP1B) and to the use thereof. More particularly, the present invention relates to diterpene furanoids which a...  
WO/2013/059582
The disclosure relates to small molecules and methods, compositions, and kits comprising these small molecules. In still another embodiment, the disclosure relates to small molecules that inhibit HDAC activity. In yet another embodiment,...  
WO/2013/059215
Disclosed herein are substituted biaryl alkyl amide compounds, methods of synthesizing substituted biaryl alkyl amide compounds and methods of treating diseases and/or conditions with substituted biaryl alkyl amide compounds.  
WO/2013/058631
The present invention relates to a diterpene furanoids compound which inhibits an activity of protein tyrosine phosphatase 1B (PTP1B) and to the use thereof. More particularly, the present invention relates to diterpene furanoids which a...  
WO/2013/053046
The present application, relates to iron bisphenolate complexes and methods of use and synthesis thereof. The iron complexes are prepared from tridentate or tetradentate ligands of Formula I: wherein R1 and R2 are as defined herein. Also...  
WO/2013/053287
(-)-(S)-3-(3'-hydroxy)-butylphthalide (a compound shown by Formula I) and an ester formed of the same and an acid are proved by experiments to be applicable to treatment and prevention of cerebral ischemic diseases and have a sleep-impro...  
WO/2013/053816
The present invention relates to a process for producing 5-hydroxymethylfurfural (HMF) from fructose in a single-phase aqueous solution comprising an organic solvent.  
WO/2013/055577
The present invention provides novel selective androgen receptor modulators and their salts and pharmaceutical compositions thereof.  
WO/2013/050301
The present invention relates to processes for the enantio-selective preparation of spyrrolidine derivatives useful in the manufacture of pesticidally active compounds, as well as to intermedates in the processes. The processes include t...  
WO/2013/044371
A compound according to Formula IA and IB, reversibly convertible under photochromic and electrochromic conditions between a ring-open isomer A and a ring-closed isomer B is provided. For substitutent groups, Z is N, O or S; each R1 is i...  
WO/2013/047904
The present invention provides a novel compound having a control efficacy on harmful arthropods. A compound represented by Formula (I): wherein Y represents a 3-7-membered saturated heterocyclic group containing one or more atoms or grou...  
WO/2013/049711
Provided are methods of producing 2,5-furandicarboxylic acid (FDCA) from renewable sources such as seaweed, alginate, oligoalginate, pectin, oligopectin, polygalacturonate, galacturonate, and/or oligogalacturonate. The sugars in the rene...  
WO/2013/047055
Provided is a heat shock protein expression inducer based on a heat shock protein (HSP) expression-inducing action. The present invention is a heat shock protein (HSP) expression inducer comprising eupalinolide A and/or B, the heat shock...  
WO/2013/047044
The present invention is a composition for forming a film for liquid-immersion exposure, said composition containing the following: a polymer component (A) containing a polymer (a1) that has a constitutional unit (I) represented by diagr...  
WO/2013/047984
The present invention relates to a method for producing a furan-based compound using an ion exchange resin in the presence of an organic solvent. In the method for producing a furan-based compound according to the present invention, a fu...  
WO/2013/042769
This aromatic amine derivative is represented by general formula (1). In general formula (1), R2, R3, R4, R5, R7, R8, R9, and R10 each independently are a hydrogen atom or a substituent group. In general formula (1): R1 and R6 are repres...  
WO/2013/041807
The present invention relates to compounds having the following formula (I-I): in which A represents a cycle chosen from the group comprising the aryl, heteroaryl, C5-8 cycloalkenyl, and heterocycloalkenyl groups, said cycle (A) being op...  
WO/2013/041895
The invention relates to novel compounds of general formula (I), and their preparation, pharmaceutical preparations containing compounds of general formula (I), and the use of these compounds in therapeutic procedures. The invention also...  
WO/2013/043131
Disclosed herein is a process for preparing 5-hydroxymethylfurfural comprising the step of contacting a carbohydrate and a Brønsted acid in an alcoholic solvent comprising an alcohol selected from the group consisting of secondary alcoh...  
WO/2013/042124
Compound of formula X wherein P1 is a fused-ring system comprising one 6-membered and two 5- membered rings; v indicates an S or R configuration; or individual isomers or pharmaceutically acceptable salts thereof, or mixtures thereof, in...  
WO/2013/042775
An aromatic amine derivative represented by general formula (1-1). In general formula (1-1), R2-R5 and R7-R10 are each independently a hydrogen atom or a substituent group. In general formula (1-1), R1 and R6 are represented by general f...  
WO/2013/042138
A process for the preparation of 4-[4-[4-[4-[[(3R,5R)-5-(2,4-difluorophenyl) tetrahydro-5-(lH-l,2,4-triazol-l-ylmefhyl) -3-furanyl]mefhoxy] phenyl] -1 -piperazinyl] phenyl]-2-[(lS,2S)-l-efhyl-2-hydroxypropyl]-2,4-dihydro-3H-l ,2,4-triazo...  
WO/2013/042124
Compound of formula X wherein P1 is a fused-ring system comprising one 6-membered and two 5- membered rings; v indicates an S or R configuration; or individual isomers or pharmaceutically acceptable salts thereof, or mixtures thereof, in...  
WO/2013/040068
The presently disclosed subject matter provides methods of preparing synthetic prostacyclin analogues, including Beraprost, either as racemic mixtures or as single stereoisomers. Also provided are novel synthetic intermediates for use in...  
WO/2013/039184
An aromatic amine derivative represented by general formula (1). In general formula (1), R1 to R10 each independently are a hydrogen atom or a substituent group. In general formula (1), any one of R1 to R10 is represented by general form...  
WO/2013/040540
A composition comprising between 95 and 100% biobased succinic acid, MAS or DAS wherein at least 75 % of the carbons are biobased.  
WO/2013/040068
The presently disclosed subject matter provides methods of preparing synthetic prostacyclin analogues, including Beraprost, either as racemic mixtures or as single stereoisomers. Also provided are novel synthetic intermediates for use in...  
WO/2013/039221
An aromatic amine derivative represented by general formula (1). In general formula (1), R1 to R10 each independently are a hydrogen atom or substituent group. In general formula (1), R1 is represented by general formula (2), and any one...  
WO/2013/038430
Disclosed herein is 10-α/β-D-Arabinofuranosylundecenes of general Formula (II) or pharmaceutically acceptable salts thereof as anti-mycobacterial agents in vitro; (II) wherein R, R1 and R" are as defined herein in the specification. Th...  
WO/2013/038931
This method of cheaply and easily producing a 2-oxo-2H-cyclohepta[b]furan analogue useful as a pharmaceutical intermediate with high purity and high yields. In this method, a 2-oxo-2H-cyclohepta[b]furan analogue represented by general fo...  
WO/2013/038650
A compound represented by formula (1). (In the formula, A1 represents O, S, Si(Ar1)(Ar2), P(=O)(Ar3)(Ar4), a substituted or unsubstituted arylene group having 6 to 30 ring-forming carbon atoms, or a substituted or unsubstituted heteroary...  
WO/2013/033971
The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, ...  
WO/2013/034048
The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, ...  
WO/2013/033899
The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, ...  
WO/2013/033058
A process is provided for carrying out an oxidation on a sprayable feed including a furanic substrate to be oxidized and a catalytically effective combination of cobalt, manganese, and bromide components for catalyzing the oxidation of t...  
WO/2013/029479
Disclosed in the present invention is a mycophenolic acid derivative shown by the following general formula (V) and the pharmaceutically acceptable salts thereof, wherein L1 is -O-R2, -QCOOR2 or -QCONR2R3, Q is C1~C10. Alkylidene or C1~C...  
WO/2013/033081
A process is provided for carrying out an oxidation on a feed including levulinic acid and/or a levulinic acid oxidation precursor to succinic acid, one or more furanic oxidation precursors of 2,5-furandicarboxylic acid and a catalytical...  
WO/2013/029555
Provided are lavendustin A derivatives, a preparation method and use thereof. The compounds are shown by the structure of formula (I), wherein R is alkyl, ether group, carbonyl, p-tolyl, five-membered heterocyclic group, five-membered su...  
WO/2013/030131
The invention relates to a method for producing furfural by reacting pentose in water and in the presence of carboxylic acid and a heterogeneous acid catalyst, said method being carried out in an aqueous solution of carboxylic acid as th...  
WO/2013/033081
A process is provided for carrying out an oxidation on a feed including levulinic acid and/or a levulinic acid oxidation precursor to succinic acid, one or more furanic oxidation precursors of 2,5-furandicarboxylic acid and a catalytical...  
WO/2013/030193
The present invention relates to γ,δ-unsaturated a-amino acids of general formula (I). The present invention also provides a versatile process for the stereospecific synthesis of said compounds of formula (I), involving a Wittig reacti...  
WO/2013/026392
A 3-(α-methoxyl) methylene benzofuran-2(3H)-ketone synthesis method comprises the synthesis of O-hydroxy phenylacetic acid, the synthesis of lactone and the synthesis of an end product, with focus on lactone synthesis improvement, such ...  
WO/2013/026726
The present invention provides compounds of formula I wherein Q is Q1 or Q2; A1, A2, A3 and A4 are independently of each other C-H, C-R7, or nitrogen; R1 is C1-C8haloalkyl; R2 is aryl or aryl substituted by one to five R11, or heteroaryl...  
WO/2013/028307
This application relates to derivatives of hydrocarbon terpenes (e.g., myrcene or farnesene), to methods of making the derivatives, and to the use of the derivatives as oils, solvents, lubricants, additives or base oils for lubricant com...  
WO/2013/026455
The present invention provides compounds comprising a substructure of below formula 3: or a salt or prodrug thereof and the use of such compounds in treatment of e.g. CNS disorders.  
WO/2013/026737
The invention relates to a method for producing γ-hydroxycarboxylic esters and γ-lactones, which are suitable as aromatic substances, by electrochemical reductive cross-coupling of α,β-unsaturated esters with carbonyl compounds in an...  
WO/2013/027774
The purpose of the present invention is, in the production of produce gamma-butyrolactone by the dehydrogenation reaction of 1,4-butanediol in the presence of a catalyst, to produce gamma-butyrolactone with high efficiency by preventing ...  
WO/2013/027694
The purpose of the present invention is to provide a near infrared light-emitting compound which has an ability to highly specifically binding to Aβ, a high permeability through the blood-brain barrier, an ability to quickly disappear f...  

Matches 301 - 350 out of 14,031